Brazil Genome Editing Market Size & Outlook, 2024-2030
Brazil genome editing market, 2018-2030 (US$M)
Related Markets
Brazil genome editing market highlights
- The Brazil genome editing market generated a revenue of USD 223.4 million in 2023 and is expected to reach USD 660.7 million by 2030.
- The Brazil market is expected to grow at a CAGR of 16.8% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 223.4 million |
| Market revenue in 2030 | USD 660.7 million |
| Growth rate | 16.8% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.8% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil genome editing market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 660.7 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 44.09% in 2024. Horizon Databook has segmented the Brazil genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Brazilian farmers are adopting advanced genome editing technologies to develop new crops that benefit farmers and consumers. For instance, researchers at the University of Sao & Federal University of Vicosa in Brazil entered into a partnership with researchers from Germany and the U.S. They developed a new tomato crop from wild plants, using CRISPR-Cas9 genome editing technology.
This new variety yields 10 times the number of fruits compared to the wild type.In addition, fruits are three times bigger in size. Furthermore, increasing usage of CRISPR genome editing technology for multiple research projects is expected to fuel market growth over the forecast period. In Brazil, CRISPR technology is used for several applications, ranging from drug screening to functional genomics.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil genome editing market size, by technology, 2018-2030 (US$M)
Brazil Genome Editing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
